LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN
Go back to LECANEMAB RECEIVES PRIORITY REVIEW STATUS IN JAPAN| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 202.93 -0.02 (0.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $202.95 | 52 Week High | $333.65 | |||
| Open | $203.34 | 52 Week Low | $223.02 | |||
| Day High | $203.85 | P/E | 25.98 | |||
| Day Low | $199.58 | EPS | $7.81 | |||
| Volume | 137,440 | |||||
| Eisai Co Ltd American Depositary Shares (AMEX: ESALY) | Delayed: 61.51 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.51 | 52 Week High | $67.60 | |||
| Open | $49.73 | 52 Week Low | $53.55 | |||
| Day High | $61.51 | P/E | N/A | |||
| Day Low | $61.51 | EPS | $0.00 | |||
| Volume | 1,907,007 | |||||
